BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36833355)

  • 1. Hereditary Cancer Syndrome in a Family with Double Mutation in
    D'Elia G; Caliendo G; Passariello L; Albanese L; Makker J; Molinari AM; Vietri MT
    Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of germline mutations in northern Brazil: a panel of 16 genes for hereditary cancer-predisposing syndrome investigation.
    Vidal AF; Ferraz RS; El-Husny A; Silva CS; Vinasco-Sandoval T; Magalhães L; Raiol-Moraes M; Barra WF; Pereira CLBL; de Assumpção PP; de Brito LM; Vialle RA; Santos S; Ribeiro-Dos-Santos Â; Ribeiro-Dos-Santos AM
    BMC Cancer; 2021 Apr; 21(1):363. PubMed ID: 33827469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited DNA repair gene mutations detected by tumor next generation sequencing in urinary tract cancers.
    Gupta S; Greenberg S; Grimmett J; Gaston D; Agarwal N; Lowrance W; Schiffman J; Kohlmann W
    Fam Cancer; 2017 Oct; 16(4):545-550. PubMed ID: 28315974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
    Tsaousis GN; Papadopoulou E; Apessos A; Agiannitopoulos K; Pepe G; Kampouri S; Diamantopoulos N; Floros T; Iosifidou R; Katopodi O; Koumarianou A; Markopoulos C; Papazisis K; Venizelos V; Xanthakis I; Xepapadakis G; Banu E; Eniu DT; Negru S; Stanculeanu DL; Ungureanu A; Ozmen V; Tansan S; Tekinel M; Yalcin S; Nasioulas G
    BMC Cancer; 2019 Jun; 19(1):535. PubMed ID: 31159747
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Martín-Morales L; Garre P; Lorca V; Cazorla M; Llovet P; Bando I; García-Barberan V; González-Morales ML; Esteban-Jurado C; de la Hoya M; Castellví-Bel S; Caldés T
    Cancer Prev Res (Phila); 2021 Feb; 14(2):185-194. PubMed ID: 33115781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A germline mutation in Rab43 gene identified from a cancer family predisposes to a hereditary liver-colon cancer syndrome.
    Jiang Y; Sun Y; Hu J; Yu N; Liu H; Fan J; Ning X; Li Y; Liu B; Sun Y; Zhang J; Qiu X; Fu S; Zhou C; Xu H
    BMC Cancer; 2019 Jun; 19(1):613. PubMed ID: 31226964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double mutation of APC and BRCA1 in an Italian family.
    Vietri MT; D'Elia G; Caliendo G; Casamassimi A; Resse M; Passariello L; Cioffi M; Molinari AM
    Cancer Genet; 2020 Jun; 244():32-35. PubMed ID: 32388397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Risk of Hereditary Prostate Cancer in Italian Families with Hereditary Breast and Ovarian Cancer Syndrome Harboring Mutations in
    D'Elia G; Caliendo G; Tzioni MM; Albanese L; Passariello L; Molinari AM; Vietri MT
    Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2.
    Schoolmeester JK; Moyer AM; Goodenberger ML; Keeney GL; Carter JM; Bakkum-Gamez JN
    Hum Pathol; 2017 Dec; 70():14-26. PubMed ID: 28709830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.
    Pearlman R; Frankel WL; Swanson B; Zhao W; Yilmaz A; Miller K; Bacher J; Bigley C; Nelsen L; Goodfellow PJ; Goldberg RM; Paskett E; Shields PG; Freudenheim JL; Stanich PP; Lattimer I; Arnold M; Liyanarachchi S; Kalady M; Heald B; Greenwood C; Paquette I; Prues M; Draper DJ; Lindeman C; Kuebler JP; Reynolds K; Brell JM; Shaper AA; Mahesh S; Buie N; Weeman K; Shine K; Haut M; Edwards J; Bastola S; Wickham K; Khanduja KS; Zacks R; Pritchard CC; Shirts BH; Jacobson A; Allen B; de la Chapelle A; Hampel H;
    JAMA Oncol; 2017 Apr; 3(4):464-471. PubMed ID: 27978560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Individual with Both MUTYH-Associated Polyposis and Lynch Syndrome Identified by Multi-Gene Hereditary Cancer Panel Testing: A Case Report.
    Cohen SA; Tan CA; Bisson R
    Front Genet; 2016; 7():36. PubMed ID: 27014339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hereditary breast carcinomas pathologist's perspective].
    Vincent-Salomon A; Bataillon G; Djerroudi L
    Ann Pathol; 2020 Apr; 40(2):78-84. PubMed ID: 32241645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a germline variant TNS1 c.2999-1G > C in a hereditary cancer syndrome family.
    Di X; Wang D; Wu J; Zhu X; Wang Y; Yan J; Wen L; Jiang H; Wen D; Shu B; Zhang S
    Gene; 2024 May; 908():148304. PubMed ID: 38387708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent pathogenic variations in patients with hereditary cancer syndromes.
    Agaoglu NB; Doganay L
    Eur J Med Genet; 2021 Dec; 64(12):104366. PubMed ID: 34637943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Report: The Role of Molecular Analysis of the
    Fabišíková K; Hamidová O; Behulová RL; Závodná K; Priščáková P; Repiská V
    Front Genet; 2020; 11():590486. PubMed ID: 33384714
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast Cancer.
    Chang-Claude J; Becher H; Caligo M; Eccles D; Evans G; Haites N; Hodgson S; Møller P; Weber BH; Stoppa-Lyonnet D
    Dis Markers; 1999 Oct; 15(1-3):53-65. PubMed ID: 10595253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for Preventive Care for Women with Rare Genetic Cause of Breast and Ovarian Cancer.
    Foretová L; Navrátilová M; Svoboda M; Vašíčková P; Sťahlová EH; Házová J; Kleiblová P; Kleibl Z; Macháčková E; Palácová M; Petráková K
    Klin Onkol; 2019; 32(Supplementum2):6-13. PubMed ID: 31409076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Germline Mutations in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test.
    Shin HC; Lee HB; Yoo TK; Lee ES; Kim RN; Park B; Yoon KA; Park C; Lee ES; Moon HG; Noh DY; Kong SY; Han W
    Cancer Res Treat; 2020 Jul; 52(3):697-713. PubMed ID: 32019277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Contribution of Next-Generation Sequencing Multigene Panel Testing for BRCA Negative High-Risk Patients With Breast Cancer.
    Ece Solmaz A; Yeniay L; Gökmen E; Zekioğlu O; Haydaroğlu A; Bilgen I; Özkınay F; Onay H
    Clin Breast Cancer; 2021 Dec; 21(6):e647-e653. PubMed ID: 33980423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Germline Variants in 450 Breast/Ovarian Cancer Families with a Multi-Gene Panel Including Coding and Regulatory Regions.
    Guglielmi C; Scarpitta R; Gambino G; Conti E; Bellè F; Tancredi M; Cervelli T; Falaschi E; Cosini C; Aretini P; Congregati C; Marino M; Patruno M; Pilato B; Spina F; Balestrino L; Tenedini E; Carnevali I; Cortesi L; Tagliafico E; Tibiletti MG; Tommasi S; Ghilli M; Vivanet C; Galli A; Caligo MA
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.